IMMULAB: A Phase II Trial of Immunotherapy with Pembrolizumab in Combination with Local Ablation for Patients with Early Stage Hepatocellular Carcinoma (hcc)—the IKF-IMMULAB Trial.
Journal of Clinical Oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined